| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 06/18/2009 | WO2009074862A1 Polymorphic forms of a 3-pyrrole substituted 2-indolinone |
| 06/18/2009 | WO2009074782A1 Cannabinoid receptor modulators |
| 06/18/2009 | WO2009074590A1 N- (2 { [1-phenyl-1h-indaz0l-4-yl] amino} propyl) -sulfonamide derivatives as non-steroidal glucocorticoid receptor ligands for the treatment of inflammations |
| 06/18/2009 | WO2009074575A2 Organic compounds |
| 06/18/2009 | WO2009074300A2 Hedgehog pathway antagonists and therapeutic applications thereof |
| 06/18/2009 | WO2009074157A1 Fully-modified phenyl pyrrole aminoguanidines |
| 06/18/2009 | WO2009074019A1 Proteinase inhibitors useful for treating cancer |
| 06/18/2009 | WO2009073973A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/18/2009 | WO2009038385A3 Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same |
| 06/18/2009 | WO2009036996A3 Small molecule bradykinin b1 receptor antagonists |
| 06/18/2009 | WO2008099000A3 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions |
| 06/18/2009 | WO2008072053A8 Substituted arylpyrazoles |
| 06/18/2009 | WO2007124337A8 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 06/18/2009 | US20090156822 Hepatitis C Inhibitor Dipeptide Analogs |
| 06/18/2009 | US20090156821 Quinazoline compounds |
| 06/18/2009 | US20090156811 Process for the Preparation of Bosentan |
| 06/18/2009 | US20090156809 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 06/18/2009 | US20090156642 5-Membered heterocyclic compound |
| 06/18/2009 | US20090156640 Nociceptin analogs |
| 06/18/2009 | US20090156622 2,4-pyrimidinediamine compounds and their uses |
| 06/18/2009 | US20090156619 Heterocycle Substituted Amide and Sulfur Amide Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 06/18/2009 | US20090156613 Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor |
| 06/18/2009 | US20090156612 Substituted imidazole compound and use thereof |
| 06/18/2009 | US20090156608 Pyridazine Compound and Use Thereof |
| 06/18/2009 | US20090156607 2-oxo-1-pyrrolidine derivatives |
| 06/18/2009 | US20090156598 Imidazolopyrimidine modulators of TRPV1 |
| 06/18/2009 | US20090156589 1,2-di(cyclic group)substituted benzene derivative |
| 06/18/2009 | US20090156586 Compounds for the treatment of inflammatory disorders |
| 06/18/2009 | US20090156585 Organic compounds |
| 06/18/2009 | US20090156582 Pyrazole Compound |
| 06/18/2009 | US20090156576 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases |
| 06/18/2009 | US20090156573 N-(Aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 06/18/2009 | US20090156571 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/18/2009 | US20090155210 Oximyl hcv serine protease inhibitors |
| 06/18/2009 | US20090155203 Thrombopoietin mimetics |
| 06/18/2009 | US20090153034 Carbazole-containing materials in phosphorescent light emittinig diodes |
| 06/18/2009 | US20090151091 Triarylmethane Dyes |
| 06/18/2009 | CA2709203A1 Hedgehog pathway antagonists and therapeutic applications thereof |
| 06/18/2009 | CA2709083A1 Polymorphic forms of a 3-pyrrole substituted 2-indolinone |
| 06/18/2009 | CA2708706A1 Cannabinoid receptor modulators |
| 06/18/2009 | CA2708241A1 Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1h-benzo[d]imidazol-2-yl)urea |
| 06/18/2009 | CA2708150A1 Fluorinated tripeptide hcv serine protease inhibitors |
| 06/18/2009 | CA2707857A1 Organic compounds |
| 06/18/2009 | CA2707313A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/18/2009 | CA2705921A1 Dual-acting benzoimidazole derivatives and their use as antihypertensive agents |
| 06/17/2009 | EP2070934A1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates |
| 06/17/2009 | EP2070922A1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
| 06/17/2009 | EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 06/17/2009 | EP2070899A1 Deprotection of N-BOC compounds |
| 06/17/2009 | EP2069333A1 Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
| 06/17/2009 | EP2069331A1 1h-indol-6-yl-piperazin-1-yl-methanone-derivatives for use as h3 receptor modulators |
| 06/17/2009 | EP2069327A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 06/17/2009 | EP2069314A1 Pyrimidines derivatives and their use as kinase inhibitors |
| 06/17/2009 | EP2069313A2 Metalloprotease inhibitors |
| 06/17/2009 | EP2069312A2 Pyridizinone derivatives |
| 06/17/2009 | EP2069310A2 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 06/17/2009 | EP2069305A2 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/17/2009 | EP1856102B1 Medicaments for alzheimer |
| 06/17/2009 | EP1836166B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/17/2009 | EP1789419B1 Gyrase inhibitors and uses thereof |
| 06/17/2009 | EP1485375B1 Pyrimidine compounds |
| 06/17/2009 | EP1472230B1 Ansamycins having improved pharmacological and biological properties |
| 06/17/2009 | EP1357115B1 Alkanoic acid derivatives, process for their production and use thereof |
| 06/17/2009 | EP1171428B1 Fab i inhibitors |
| 06/17/2009 | CN100502087C 场致发光器件 Electroluminescent device |
| 06/16/2009 | US7547782 Met kinase inhibitors |
| 06/16/2009 | US7547717 2-thioxo-4-imidazolines; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 06/16/2009 | US7547702 Glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents |
| 06/16/2009 | US7547698 Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD) |
| 06/16/2009 | US7547693 Piperidine derivative |
| 06/16/2009 | CA2452217C Hiv inhibiting pyrimidines derivatives |
| 06/16/2009 | CA2451474C Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 06/11/2009 | WO2009073779A1 Gamma secretase modulators |
| 06/11/2009 | WO2009073777A1 Gamma secretase modulators |
| 06/11/2009 | WO2009072621A1 Substituted dihydroazole compound and pest control agent |
| 06/11/2009 | WO2009072137A2 Process for pure irbesartan |
| 06/11/2009 | WO2009071906A1 Derivatives of 1-[(imidazolidin-2-yl)imino)]indazole |
| 06/11/2009 | WO2009071701A1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases |
| 06/11/2009 | WO2009071677A1 New compounds iii |
| 06/11/2009 | WO2009071535A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 06/11/2009 | WO2009071509A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 06/11/2009 | WO2009071101A1 N-modified aminoguanidine derivatives |
| 06/11/2009 | US20090149662 Processes for preparing zafirlukast |
| 06/11/2009 | US20090149650 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 06/11/2009 | US20090149649 Aromatic hetrocyclic compound, organic light-emitting diode including organic layer comprising the aromatic hetrocyclic compound, and method of manufacturing the organic light-emitting diode |
| 06/11/2009 | US20090149528 Cinnamic acid amides |
| 06/11/2009 | US20090149521 Dual-acting benzoimidazole antihypertensive agents |
| 06/11/2009 | US20090149509 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium; 2 (S)-hydroxy-3 (R)-[2 (S)-oxazol-2-yl-pyrrolidine-1-carbonyl)-heptanoic acid hydroxamide |
| 06/11/2009 | US20090149504 Novel 5-Substituted Indole Derivatives As Dipeptidyl Peptidase IV (DPP-IV) Inhibitors |
| 06/11/2009 | US20090149472 Salts of substitutted pyrazoline compounds, their preparation and use and medicaments |
| 06/11/2009 | US20090149471 Monocyclic Heterocyclic Compounds |
| 06/11/2009 | US20090149469 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors |
| 06/11/2009 | US20090149467 Tyrosine Kinase Inhibitors |
| 06/11/2009 | US20090149466 Inhibitors of stearoyl-coa desaturase |
| 06/11/2009 | US20090149464 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases |
| 06/11/2009 | US20090149460 New Compounds |
| 06/11/2009 | US20090149459 P38 inhibitors and methods of use thereof |
| 06/11/2009 | US20090149447 Novel M3 Muscarinic Acetylcholine Receptor Antagonists |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149443 P38 inhibitors and methods of use thereof |